NCT05065151Recruiting
Understanding Motivation in Parkinson's Patients Through Neurophysiology
Source: ClinicalTrials.gov · Last updated 5 Jun 2026
Brief summary (registry, in English)
The study aims to better understand motivation and value-based decision-making in Parkinson's patients through neurophysiology using Medtronic's Percept DBS device. By combining behavioral tasks with neural recordings, the study seeks to uncover how DBS affects motivation, particularly in relation to effort, reward, and timing.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 17 Sept 2021
- Start date
- 30 Oct 2021
- Primary completion date
- 1 Dec 2030
- Lead sponsor
- University of California, San Francisco
- Diseases
- Parkinson disease
- NCT number
- NCT05065151
What you commit to
- Study type: Interventional
- Planned participants: 70
- From 30 Oct 2021 to the primary completion date, 1 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age less than 18 years old
Other
- Severe cognitive impairments
- Has MOCA score below 20
- Pregnancy
Who the study is looking for
- Has Parkinson's Disease or Dystonia
- Has Medtronic Percept or RC+S DBS device implanted in either GPI or STN
- Has DBS device implanted either bilaterally or unilaterally
- Male or female
- More than 1 month post-DBS surgery
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.